(hPG) A mixture of follicle stimulating hormone (FSH) and luteinising hormone (LH) extracted directly from pituitary glands obtained at autopsies; not used in Australia or elsewhere since 1986, when it was shown that Creutzfeldt-Jakob disease (CJD), a deadly form of dementia, had been transmitted from its use, presumably due to contaminating and infected brain tissue. Before 1986 it had been used mostly for ovulation induction in women with amenorrhea (absent periods) for which other hormones or drugs had not been effective, although sporadic instances of its use for in vitro fertilisation are known in Australia. No new cases of CJD have been reported among former users of hPG since the early 1990s.

(FSH) The hormone, or gonadotropin, produced by the pituitary gland that in women stimulates the tertiary follicle to grow; in men it stimulates spermatogenesis. Obtained from human sources in a mixture with luteinising hormone (LH) as (1) human menopausal gonadotropin (hMG), extracted from the urine of women who have been through the menopause (Humegon, Metrodin and Pergonal); and (2) human pituitary gonadotropin (hPG), from human pituitary glands removed at autopsies (now obsolete). Today, pure FSH is made synthetically with gene technology (recombinant FSH), such as Gonal-F and Puregon.

(hMG) A mixture of follicle stimulating hormone (FSH) and luteinising hormone (LH) extracted for therapeutic use from the urine of menopausal women (women after the menopause normally produce these hormones in high concentration). Marketed as Humegon (Organon) and Pergonal (Serono). Metrodin (Serono) is hMG from which LH has been removed, and Metrodin HP (Serono) is Metrodin from which other urinary proteins have been removed too, resulting in very pure FSH. Ferring market a highly purified hMG containing both FSH and LH, but not in Australia (see Menogon or Repronex). No cases of transmitted (infectious) disease have been recorded after the use of hMG preparations, unlike human pituitary gonadotropin.

(rFSH) Follicle stimulating hormone derived from genetic engineering instead of being extracted from the urine of postmenopausal women (human menopausal gonadotropin, or hMG) or from the pituitary glands of cadavers (human pituitary gonadotropin, or hPG). Produced and marketed by the two pharmaceutical companies Organon (as Puregon), or Fertinex in the US and Serono (as Gonal-F) to replace their hMG preparations. Has the advantage over hMG (and its purified derivatives) of being standard in biological structure and activity, and of not being of a human source (hPG -- but not hMG -- having been implicated in transmission of Creutzfeldt-Jakob disease).